Manufacturing Novartis unveils North Carolina API plant as final piece of $23B US expansion BioSpaceThe new plant will give Novartis end-to-end capabilities centered on North Carolina, where it plans to have five facilities across three sites.Read full story pharminent May 1, 2026 (Last updated: May 1, 2026) BioSpace The new plant will give Novartis end-to-end capabilities centered on North Carolina, where it plans to have five facilities across three sites. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Amgen positions MariTide as potential ‘best monthly’ obesity drugNext: Pfizer, Arvinas join SERD club with Veppanu approval Related Stories Manufacturing FUJIFILM opens new iPSC facility in Madison, US pharminent May 21, 2026 Manufacturing Pharma’s manufacturing reconfigurations provide CDMOs with expansion opportunities pharminent May 12, 2026 Manufacturing Eli Lilly pledges $4.5bn to bolster Indiana-based manufacturing pharminent May 7, 2026
